Thyroid cancer Flashcards

1
Q

How common is thyroid cancer in the UK?

A
  • Fairly rare, about 3500 new cases per year in the UK
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

At what age is thyroid cancer most likely to present in each gender?

A
  • Most commonly between ages 35 and 39 in women and is much more common in women
  • much later in males- most commonly 70+
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the survival rate of thyroid cancer?

A

85% of patients survive their cancer for 10 years or more.
This is much lower though for anaplastic thyroid cancer- only 5% will survive 5 years or more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 5 types of thyroid cancer?

A
  • Papillary
  • Follicular
  • Hurthle cell carcinoma
  • Medullary
  • Anaplastic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the characteristics of papillary thyroid cancer?

A
  • The most common with about 90% of thyroid cancers
  • more common in women and younger people
  • usually slow growing but can spread to lymph nodes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the characteristics of follicular thyroid cancer?

A
  • often diagnosed in middle age and women
  • make up about 4% of thyroid cancers
  • sometimes spread to the lungs or bones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the characteristics of Hurthle cell thyroid cancer?

A
  • Rare type of thyroid cancer- only 2%
  • often associated with follicular cancer as it shares similar characteritics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the characteristics of medullary thyroid cancer?

A
  • rare (2% of thyroid cancers)
  • about 25% of medullary cancers are caused by an inherited faulty gene that runs in the family
  • can spread to liver and lungs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the characteristics of anaplastic thyroid cancer?

A

The least common type of thyoid cancer ( about 1% of cancers) but also the most severe
- usually diagnosed in older people and is more common in women
- the cells dont look like normal throid cells and tend to grow much quicker than other thyroid cancers
- has a very poor prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some risk factors for thyroid cancer?

A
  • Gender- more common in women (72% of cases are women)
  • obesity
  • Family history of cancer
  • exposure to radiation e.g. chernobyl
  • non-cancerous benign diseases of the thyroid e.g. Hashimottos syndrome, goitre
  • Gentic factors such as inherited genes- e.g. changes in the Ret gene can cause MEN2A and MEN2B syndromes (Multiple endocrine neoplasia). About 25% of people with medulary thyroid cancer have an inherited faulty gene associated with MEN.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the link between multiple endocrine neoplasia and thyroid cancer?

A

Gentic factors such as inherited genes- e.g. changes in the Ret gene can cause MEN2A and MEN2B syndromes (Multiple endocrine neoplasia). About 25% of people with medulary thyroid cancer have an inherited faulty gene associated with MEN.
- most people with MEN syndromes are offered surgery to remove their thyroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the symptoms of thyroid cancer?

A
  • Lump in neck
  • Enlarged thyroid (goitre)
  • Hoarseness of voice
  • Sore throat
  • Difficulty swallowing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the treatment options for thyroid cancer?

A
  • Surgery to remove the thyroid gland
  • Radiotherapy with radioiodine (I131)
  • Chemotherapy- most commonly Doxorubucin or Cisplatin
  • If these options are unsuccessful, may use targeted chemotherapy in which they target the vascular endothelial growth factor receptor pathways as the thyroid is vascular-rich
    e.g. Vandetanib (Medullary)- targets the VEGFR2 and EGFR
    Cabozantinib (medullary)- inhibits c-MET and VEGFR2
    Lenvatininb (follicular & papillary)- inhibits VEGFR and FGFR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is VEGFR2?

A

Vascular endothelial growth factor receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is EGFR?

A

Epidermal growth factor receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is c-MET?

A

Mesenchymal epithelial transition factor

17
Q

What is FGFR?

A

Fibroblast growth factor receptors